Microstructural injury to the optic nerve with vigabatrin treatment in West syndrome: A DTI study

Junjie Hu1, Li Chen2, Gongwei Zhang3

  • 1Department of Pediatric, Sihui People's Hospital, Zhaoqing, China.

Scientific Reports
|July 16, 2025
PubMed

Insights

Vigabatrin treatment in children with West syndrome can cause optic nerve injury, detectable by diffusion tensor imaging. Fractional anisotropy values indicate injury and reversibility after discontinuing vigabatrin.

Area of Science:

  • Neuroimaging
  • Pediatric Neurology
  • Ophthalmology

Background:

  • West syndrome is a severe infant epilepsy.
  • Vigabatrin is a common anti-seizure medication.
  • Optic nerve abnormalities are a known side effect of vigabatrin.

Purpose of the Study:

  • To evaluate optic nerve injury in children with West syndrome treated with vigabatrin using diffusion tensor imaging (DTI).
  • To identify imaging biomarkers for vigabatrin-induced optic nerve damage.
  • To assess the reversibility of these changes.

Main Methods:

  • Retrospective analysis of 35 children with West syndrome.
  • Grouping based on vigabatrin treatment and thalamic abnormalities.
  • Assessment of optic nerve fractional anisotropy (FA) and apparent diffusion coefficient (ADC) using DTI.
  • Receiver operating characteristic (ROC) curve analysis to determine FA thresholds for injury.

Main Results:

  • Significantly lower FA values in vigabatrin-treated children with thalamic abnormalities compared to controls.
  • No significant difference in ADC values between groups.
  • Significant increase in FA values after vigabatrin discontinuation, indicating reversibility.
  • ROC analysis identified an FA cut-off of 304 with high sensitivity and specificity for optic nerve injury.

Conclusions:

  • Fractional anisotropy (FA) is a sensitive DTI biomarker for detecting vigabatrin-related optic nerve injury in West syndrome.
  • Thalamic abnormalities may correlate with the severity of optic nerve injury.
  • Vigabatrin-induced optic nerve changes appear reversible upon treatment cessation.

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
579
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
697
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
775